Deepak L. Bhatt
Brigham and Women's Hospital
CardiologyMyocardial infarctionStrokeDiabetes mellitusMedicine
What is this?
Publications 2303
#1Sameer A. Hirji (Brigham and Women's Hospital)H-Index: 9
#2Cheryl K. Zogg (Yale University)H-Index: 16
Last. Patrick O' Gara (Brigham and Women's Hospital)H-Index: 71
view all 11 authors...
Abstract The Center for Medicare & Medicaid Services has identified readmission as an important quality metric in assessing hospital performance and value of care. The aim of this study was to quantify the impact of “care fragmentation” on transcatheter aortic valve implantation (TAVI) outcomes. Readmission to non-index hospitals was defined as any hospital other than the hospital where the TAVI was performed. In this multi-center, population-based, nationally-representative study, a nationally-...
#1Anne Marie Valente (Brigham and Women's Hospital)H-Index: 35
#2Deepak L. Bhatt (Brigham and Women's Hospital)H-Index: 127
Last. Abbi D. Lane-Cordova (USC: University of South Carolina)H-Index: 6
view all 3 authors...
#1Islam Y. Elgendy (Harvard University)H-Index: 20
#2Ahmed N. Mahmoud (UW: University of Washington)H-Index: 18
Last. Deepak L. Bhatt (Brigham and Women's Hospital)H-Index: 127
view all 5 authors...
1 CitationsSource
#1Raj Makkar (Cedars-Sinai Medical Center)H-Index: 68
#2Wen Cheng (Cedars-Sinai Medical Center)H-Index: 24
Last. James B. HermillerH-Index: 55
view all 28 authors...
Summary Background Randomised trial data assessing the safety and efficacy of the self-expanding intra-annular Portico transcatheter aortic valve system (Abbott Structural Heart, St Paul, MN, USA) compared with any commercially available valves are needed to compare performance among designs. Methods In this prospective, multicentre, non-inferiority, randomised controlled trial (the Portico Re-sheathable Transcatheter Aortic Valve System US Investigational Device Exemption trial [PORTICO IDE]), ...
#1Raj Makkar (Cedars-Sinai Medical Center)H-Index: 68
#2Philipp Blanke (UBC: University of British Columbia)H-Index: 42
Last. Mathew R. Williams (NYU: New York University)H-Index: 56
view all 25 authors...
Abstract Background Subclinical leaflet thrombosis, characterized by hypoattenuated leaflet thickening (HALT) and reduced leaflet motion observed on 4-dimensional computed tomography (CT), may represent a form of bioprosthetic valve dysfunction. Objectives The U.S. Food and Drug Administration mandated CT studies to understand the natural history of this finding, differences between transcatheter and surgical valves, and its association with valve hemodynamics and clinical outcomes. Methods The ...
1 CitationsSource
#1Peter Sinnaeve (Katholieke Universiteit Leuven)H-Index: 36
#2Gregory G. Schwartz (University of Colorado Denver)H-Index: 40
view all 20 authors...
AIMS: Lowering low-density lipoprotein cholesterol (LDL-C) reduces cardiovascular risk irrespective of age, but the evidence is less strong for older patients. METHODS AND RESULTS: This prespecified analysis from ODYSSEY OUTCOMES compared the effect of alirocumab vs. placebo in 18 924 patients with recent acute coronary syndrome (ACS) according to age. We examined the effect of assigned treatment on occurrence of the primary study outcome, a composite of coronary heart disease death, myocardial ...
5 CitationsSource
#1William E. Boden (BU: Boston University)H-Index: 36
#2Deepak L. Bhatt (Brigham and Women's Hospital)H-Index: 127
Last. Thomas F. Lüscher (UZH: University of Zurich)H-Index: 125
view all 6 authors...
The aims of this clinical review are to: (i) highlight the importance of elevated baseline triglycerides (TG) in the setting of well-controlled low-density lipoprotein cholesterol (LDL-C) on statins as a major contributor to residual atherosclerotic cardiovascular disease (ASCVD) risk, particularly among patients with type 2 diabetes mellitus, metabolic syndrome, and obesity whose distinctive lipid phenotype cannot be optimally treated with LDL-C reduction therapy alone; (ii) describe the findin...
12 CitationsSource
#1Jose C. Nicolau (USP: University of São Paulo)H-Index: 46
#3Investigators (Goethe University Frankfurt)H-Index: 3
Last. Jonas Oldgren (Uppsala University)H-Index: 46
view all 13 authors...
Background and objective In patients with atrial fibrillation following percutaneous coronary intervention, if a proton pump inhibitor is used, could that allow the use of warfarin triple therapy, or is there additional reduction in bleeding while using it with dual therapy? Methods The RE-DUAL PCI trial randomized 2725 patients with atrial fibrillation post-percutaneous coronary intervention to dabigatran dual therapy (110 or 150 mg twice daily, with clopidogrel or ticagrelor) or warfarin tripl...
#1Y S Chandrashekhar (UMN: University of Minnesota)H-Index: 24
#2Thomas AlexanderH-Index: 3
Last. Jeroen J. Bax (LUMC: Leiden University Medical Center)H-Index: 110
view all 40 authors...
The 143 low- and middle-income countries (LMICs) of the world constitute 80% of the world’s population or roughly 5.86 billion people with much variation in geography, culture, literacy, financial ...
#1Yiannis S. Chatzizisis (UNMC: University of Nebraska Medical Center)H-Index: 33
#2Ganesh Gajanan (UNMC: University of Nebraska Medical Center)
Last. Thomas R. Porter (UNMC: University of Nebraska Medical Center)H-Index: 49
view all 5 authors...